REGENERON PHARMACEUTIC

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

26 Feb 2024 09:48:37 By NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

23 Feb 2024 09:45:04 By NetDania Notify

Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of COPD with Type 2 Inflammation

23 Feb 2024 01:00:00 By Nasdaq GlobeNewswire

Linvoseltamab BLA for Treatment of Relapsed/Refractory Multiple Myeloma Accepted for FDA Priority Review

21 Feb 2024 07:00:13 By Nasdaq GlobeNewswire

Japan First in the World to Approve Dupixent® (dupilumab) for Chronic Spontaneous Urticaria (CSU)

16 Feb 2024 00:59:00 By Nasdaq GlobeNewswire

Regeneron Announces Investor Conference Presentations

06 Feb 2024 16:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

02 Feb 2024 09:45:10 By NetDania Notify

Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

02 Feb 2024 06:30:01 By Nasdaq GlobeNewswire

Linvoseltamab Receives EMA Filing Acceptance for Treatment of Relapsed/Refractory Multiple Myeloma

02 Feb 2024 06:00:04 By Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

31 Jan 2024 09:45:04 By NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

30 Jan 2024 09:50:53 By NetDania Notify

Regeneron Announces Formation of Regeneron Cell Medicines with the Acquisition of 2seventy bio Platforms and Preclinical and Clinical Programs

30 Jan 2024 07:00:41 By Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

26 Jan 2024 09:47:16 By NetDania Notify

Dupixent® (dupilumab) FDA Approved as First and Only Treatment Indicated for Children Aged 1 Year and Older with Eosinophilic Esophagitis (EoE)

25 Jan 2024 14:29:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

25 Jan 2024 09:45:06 By NetDania Notify

Top 40 High School Scientists in Prestigious Regeneron Science Talent Search to Compete for $1.8 Million in Awards

24 Jan 2024 12:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

24 Jan 2024 09:45:06 By NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

23 Jan 2024 09:45:08 By NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

22 Jan 2024 14:22:25 By NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

17 Jan 2024 09:45:04 By NetDania Notify